{
    "nctId": "NCT05234606",
    "briefTitle": "A Safety and Preliminary Efficacy Study of SBT6290 Alone and in Combination With PD-(L)1 Inhibitors in Select Advanced Solid Tumors",
    "officialTitle": "A Phase 1/2, Open-Label, Dose-Escalation and Expansion Study of SBT6290 Alone and in Combination With PD-(L)1 Inhibitors in Subjects With Advanced Solid Tumors Associated With Nectin-4 Expression",
    "overallStatus": "WITHDRAWN",
    "conditions": "Urothelial Carcinoma, Triple Negative Breast Cancer, Non-small Cell Lung Cancer, Squamous Cell Carcinoma of Head and Neck, Hormone Receptor-positive/HER2-negative Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE1, PHASE2",
    "allocation": "NON_RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 0,
    "primaryOutcomeMeasure": "Number of Participants With Dose Limiting Toxicities: Part 1 and Part 3",
    "eligibilityCriteria": "Key Inclusion Criteria:\n\n* Locally advanced or metastatic solid tumors associated associated with Nectin-4 expression (locally advanced or metastatic urothelial carcinoma, TNBC, NSCLC, SCCHN, and HR+/HER2- negative breast cancer)\n* Measurable disease per the the Response Evaluation Criteria in Solid Tumors (RECIST) Version 1.1 criteria\n* Tumor lesion amenable for biopsy available to submit for retrospective baseline testing of Nectin-4; archived tumor tissue may be acceptable depending upon study Part detailed criteria\n* ECOG Performance Status of 0 or 1\n* Adequate organ and marrow function Note: Other protocol-defined inclusion/exclusion criteria may apply.\n\nKey Exclusion Criteria:\n\n* History of allergic reactions to certain components of study treatments\n* Untreated brain metastases\n* Currently active (or history of) autoimmune disease\n* Taking the equivalent of \\>10 mg / day of prednisone\n* Uncontrolled or clinically significant interstitial lung disease (ILD)\n* History of ongoing, uncontrolled, symptomatic eye disorders requiring intervention or associated with marked visual field defects or limiting age-appropriate instrumental activities of daily living\n* HIV infection, active hepatitis B or hepatitis C infection Note: Other protocol-defined inclusion/exclusion criteria may apply.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}